These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 38481473)

  • 1. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics.
    Frimpong-Manson K; Ortiz YT; McMahon LR; Wilkerson JL
    Front Mol Neurosci; 2024; 17():1355281. PubMed ID: 38481473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene-related peptide and beyond.
    Garelja ML; Hay DL
    Headache; 2022 Oct; 62(9):1093-1104. PubMed ID: 36226379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
    Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
    Elife; 2021 Apr; 10():. PubMed ID: 33856345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin as a model of migraine: Clinical and preclinical review.
    Sureda-Gibert P; Romero-Reyes M; Akerman S
    Neurobiol Pain; 2022; 12():100105. PubMed ID: 36974065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.
    Avona A; Burgos-Vega C; Burton MD; Akopian AN; Price TJ; Dussor G
    J Neurosci; 2019 May; 39(22):4323-4331. PubMed ID: 30962278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in targeting calcitonin gene-related peptide for the treatment of menstrual migraine: A narrative review.
    Jiang Y; Huang ZL
    Medicine (Baltimore); 2022 Jun; 101(24):e29361. PubMed ID: 35713436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors.
    Gupta S; Villalón CM
    Pharmacol Ther; 2010 Oct; 128(1):170-90. PubMed ID: 20655327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin gene relating peptide inhibitors in combination for migraine treatment: A mini-review.
    Shah T; Bedrin K; Tinsley A
    Front Pain Res (Lausanne); 2023; 4():1130239. PubMed ID: 37006413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide and its role in migraine pathophysiology.
    Arulmani U; Maassenvandenbrink A; Villalón CM; Saxena PR
    Eur J Pharmacol; 2004 Oct; 500(1-3):315-30. PubMed ID: 15464043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress.
    Wang M
    Neuropeptides; 2013 Dec; 47(6):463-6. PubMed ID: 24220568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGRP in Animal Models of Migraine.
    Wattiez AS; Wang M; Russo AF
    Handb Exp Pharmacol; 2019; 255():85-107. PubMed ID: 30689086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGRP and migraine: from bench to bedside.
    Edvinsson L
    Rev Neurol (Paris); 2021 Sep; 177(7):785-790. PubMed ID: 34275653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel Migraine Treatment: From Bench to Bedside].
    Kato Y
    Brain Nerve; 2022 Oct; 74(10):1197-1204. PubMed ID: 36198645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.
    Wattiez AS; Sowers LP; Russo AF
    Expert Opin Ther Targets; 2020 Feb; 24(2):91-100. PubMed ID: 32003253
    [No Abstract]   [Full Text] [Related]  

  • 17. New discoveries in migraine mechanisms and therapeutic targets.
    Dussor G
    Curr Opin Physiol; 2019 Oct; 11():116-124. PubMed ID: 31815209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CGRP and 5-HT
    Moreno-Ajona D; Chan C; Villar-Martínez MD; Goadsby PJ
    Headache; 2019 Jul; 59 Suppl 2():3-19. PubMed ID: 31291016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention.
    Caronna E; Alpuente A; Torres-Ferrus M; Pozo-Rosich P
    Handb Clin Neurol; 2024; 199():107-124. PubMed ID: 38307640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.